Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 283(36): 24770-80, 2008 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-18621729

RESUMO

Accumulation of indigestible lipofuscin and decreased mitochondrial energy production are characteristic age-related changes of post-mitotic retinal pigment epithelial (RPE) cells in the human eye. To test whether these two forms of age-related impairment have interdependent effects, we quantified the ATP-dependent phagocytic function of RPE cells loaded or not with the lipofuscin component A2E and inhibiting or not mitochondrial ATP synthesis either pharmacologically or genetically. We found that physiological levels of lysosomal A2E reduced mitochondrial membrane potential and inhibited oxidative phosphorylation (OXPHOS) of RPE cells. Furthermore, in media with physiological concentrations of glucose or pyruvate, A2E significantly inhibited phagocytosis. Antioxidants reversed these effects of A2E, suggesting that A2E damage is mediated by oxidative processes. Because mitochondrial mutations accumulate with aging, we generated novel genetic cellular models of RPE carrying mitochondrial DNA point mutations causing either moderate or severe mitochondrial dysfunction. Exploring these mutant RPE cells we found that, by itself, only the severe but not the moderate OXPHOS defect reduces phagocytosis. However, sub-toxic levels of lysosomal A2E are sufficient to reduce phagocytic activity of RPE with moderate OXPHOS defect and cause cell death of RPE with severe OXPHOS defect. Taken together, RPE cells rely on OXPHOS for phagocytosis when the carbon energy source is limited. Our results demonstrate that A2E accumulation exacerbates the effects of moderate mitochondrial dysfunction. They suggest that synergy of sub-toxic lysosomal and mitochondrial changes in RPE cells with age may cause RPE dysfunction that is known to contribute to human retinal diseases like age-related macular degeneration.


Assuntos
Envelhecimento/metabolismo , Lipofuscina/metabolismo , Mitocôndrias/metabolismo , Fagocitose , Epitélio Pigmentado Ocular/metabolismo , Compostos de Piridínio/metabolismo , Retinoides/metabolismo , Trifosfato de Adenosina/genética , Trifosfato de Adenosina/metabolismo , Envelhecimento/genética , Envelhecimento/patologia , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Morte Celular/efeitos dos fármacos , Morte Celular/genética , Linhagem Celular , DNA Mitocondrial/genética , DNA Mitocondrial/metabolismo , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Glucose/metabolismo , Humanos , Lipofuscina/farmacologia , Lisossomos/genética , Lisossomos/metabolismo , Lisossomos/patologia , Degeneração Macular/genética , Degeneração Macular/metabolismo , Degeneração Macular/patologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Potencial da Membrana Mitocondrial/genética , Mitocôndrias/genética , Mitocôndrias/patologia , Mitose/efeitos dos fármacos , Mitose/genética , Fosforilação Oxidativa/efeitos dos fármacos , Fagocitose/efeitos dos fármacos , Fagocitose/genética , Epitélio Pigmentado Ocular/patologia , Mutação Puntual , Compostos de Piridínio/farmacologia , Ácido Pirúvico/metabolismo , Ratos , Ratos Long-Evans , Retinoides/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA